SCHEMBL2594529

SCHEMBL2594529

S=P(c1ccccc1)(c1ccccc1)c1c(-c2ccccc2)[nH]c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 1.00
ESR1 P03372 3/20 0.52
ESR2 Q92731 3/20 0.52
CYP19A1 P11511 1/20 0.46
CNR1 P21554 1/20 0.42
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
HTR2A P28223 5/20 0.41
HTR2C P28335 3/20 0.41
KCNH2 Q12809 1/20 0.41
GPR3 P46089 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2591581 0.79 NPSR1 (1.00) NPSR1CYP19A1ALDH1A1MEN1KMT2A
SCHEMBL1074359 0.75 NPSR1 (0.60) NPSR1ESR1ESR2CYP19A1CNR1
SCHEMBL18787054 0.70 ESR1 (0.87) NPSR1ESR1ESR2CYP19A1ALDH1A1
SCHEMBL29799621 0.69 ESR1 (1.00) ESR1ESR2CYP19A1ALDH1A1KDM4E
SCHEMBL3929385 0.69 ESR1 (0.63) NPSR1ESR1ESR2CYP19A1ALDH1A1
SCHEMBL3864662 0.69 ESR1 (1.00) ESR1ESR2CYP19A1ALDH1A1KDM4E
SCHEMBL27293850 0.69 ESR1 (0.63) NPSR1ESR1ESR2CYP19A1ALDH1A1
SCHEMBL18191236 0.68 AHR (0.53) NPSR1ESR1ESR2ALDH1A1MEN1
SCHEMBL31681138 0.67 ESR1 (0.61) NPSR1ESR1ESR2CYP19A1ALDH1A1
SCHEMBL1260425 0.67 CYP11B1 (0.66) NPSR1ESR1ESR2CYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed